Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

AGA and SD share similar features, making diagnosis challenging.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Belatacept may be a promising treatment for alopecia areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Recognizing rare hair loss patterns in young females can improve understanding and treatment.

Compound follicles in folliculitis decalvans mainly have active hair follicles.

Leflunomide is more likely to help treat alopecia areata than cause it.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Tofacitinib helped regrow hair in a woman with alopecia areata.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.